| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| systematic review | Q1504425 |
| P50 | author | Feiko ter Kuile | Q37606371 |
| Kamija Phiri | Q73722711 | ||
| Mary-Ann Davies | Q79181149 | ||
| Matthias Egger | Q19996372 | ||
| P2093 | author name string | Gilles Wandeler | |
| IeDEA-Southern Africa | |||
| Nyanyiwe M Mbeye | |||
| P2860 | cites work | Anti-folate drug resistance in Africa: meta-analysis of reported dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant genotype frequencies in African Plasmodium falciparum parasite populations | Q34134036 |
| Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy. | Q34268594 | ||
| Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda | Q34359439 | ||
| Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial | Q34369756 | ||
| A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa | Q34687538 | ||
| Protective efficacy of co-trimoxazole prophylaxis against malaria in HIV exposed children in rural Uganda: a randomised clinical trial | Q34748630 | ||
| The association between malnutrition and the incidence of malaria among young HIV-infected and -uninfected Ugandan children: a prospective study | Q35914418 | ||
| HIV infection and the incidence of malaria among HIV-exposed children from Tanzania | Q36153767 | ||
| The effect of HIV on malaria in the context of the current standard of care for HIV-infected populations in Africa | Q36504556 | ||
| Reducing the burden of malaria in pregnancy by preventive strategies | Q36717628 | ||
| Co-trimoxazole prophylaxis in tropical countries in the era of highly active antiretroviral therapy: do we know enough? | Q36896070 | ||
| Impact of trimethoprim-sulfamethoxazole prophylaxis on falciparum malaria infection and disease | Q37339874 | ||
| Effects of cotrimoxazole prophylactic treatment on adverse health outcomes among HIV-exposed, uninfected infants | Q37555921 | ||
| Mapping 'partially resistant', 'fully resistant', and 'super resistant' malaria | Q38136762 | ||
| Effects of trimethoprim-sulfamethoxazole and insecticide-treated bednets on malaria among HIV-infected Ugandan children | Q38877477 | ||
| Effect of cotrimoxazole prophylaxis taken by human immunodeficiency virus (HIV)-infected persons on the selection of sulfadoxine-pyrimethamine-resistant malaria parasites among HIV-uninfected household members. | Q38879071 | ||
| The cost-effectiveness of cotrimoxazole prophylaxis in HIV-infected children in Zambia | Q46253891 | ||
| Increased severe anemia in HIV-1-exposed and HIV-1-positive infants and children during acute malaria | Q48025010 | ||
| A new world malaria map: Plasmodium falciparum endemicity in 2010 | Q17485680 | ||
| The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration | Q21092360 | ||
| Safety and efficacy of co-trimoxazole for treatment and prevention of Plasmodium falciparum malaria: a systematic review | Q21133667 | ||
| A world malaria map: Plasmodium falciparum endemicity in 2007 | Q21144643 | ||
| Drugs for preventing malaria in pregnant women | Q24244241 | ||
| PROSPERO at one year: an evaluation of its utility | Q24288905 | ||
| Intermittent preventive therapy for malaria during pregnancy using 2 vs 3 or more doses of sulfadoxine-pyrimethamine and risk of low birth weight in Africa: systematic review and meta-analysis | Q26849714 | ||
| The Cochrane Collaboration's tool for assessing risk of bias in randomised trials | Q27860509 | ||
| National policy development for cotrimoxazole prophylaxis in Malawi, Uganda and Zambia: the relationship between Context, Evidence and Links | Q30501533 | ||
| Spatiotemporal mathematical modelling of mutations of the dhps gene in African Plasmodium falciparum | Q30541962 | ||
| Severe morbidity and mortality in untreated HIV-infected children in a paediatric care programme in Abidjan, Côte d'Ivoire, 2004-2009. | Q31020587 | ||
| Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review | Q33288230 | ||
| HIV infection, malnutrition, and invasive bacterial infection among children with severe malaria | Q33785634 | ||
| Implementation of co-trimoxazole prophylaxis and isoniazid preventive therapy for people living with HIV. | Q33793347 | ||
| Plasmodium falciparum dihydrofolate reductase and dihyropteroate synthase mutations and the use of trimethoprim-sulfamethoxazole prophylaxis among persons infected with human immunodeficiency virus | Q33817605 | ||
| Effect of trimethoprim-sulphamethoxazole on the risk of malaria in HIV-infected Ugandan children living in an area of widespread antifolate resistance | Q33992235 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Sub-Saharan Africa | Q132959 |
| malaria | Q12156 | ||
| systematic review | Q1504425 | ||
| malaria prevention | Q93598033 | ||
| P304 | page(s) | 1057-1067 | |
| P577 | publication date | 2014-09-01 | |
| P1433 | published in | Tropical Medicine and International Health | Q15765747 |
| P1476 | title | Cotrimoxazole prophylactic treatment prevents malaria in children in sub-Saharan Africa: systematic review and meta-analysis | |
| P478 | volume | 19 |
| Q46564382 | Burden of asymptomatic malaria, anemia and relationship with cotrimoxazole use and CD4 cell count among HIV1-infected adults living in Gabon, Central Africa |
| Q46265061 | Cotrimoxazole prophylaxis was associated with enteric commensal bacterial resistance among HIV-exposed infants in a randomized controlled trial, Botswana |
| Q38905487 | Daily co-trimoxazole prophylaxis to prevent mortality in children with complicated severe acute malnutrition: a multicentre, double-blind, randomised placebo-controlled trial. |
| Q36886734 | Delayed acquisition of Plasmodium falciparum antigen-specific CD4(+) T cell responses in HIV-exposed uninfected Malawian children receiving daily cotrimoxazole prophylaxis |
| Q55278895 | Drugs in Development for Malaria. |
| Q38843857 | Effect of co-trimoxazole on mortality in HIV-exposed but uninfected children in Botswana (the Mpepu Study): a double-blind, randomised, placebo-controlled trial |
| Q35739147 | Effect of cotrimoxazole prophylaxis on the incidence of malaria in HIV-infected children in 2012, in Abidjan, Côte d'Ivoire: a prospective cohort study |
| Q92723500 | Efficacy and safety of dihydroartemisinin-piperaquine for treatment of Plasmodium falciparum uncomplicated malaria in adult patients on antiretroviral therapy in Malawi and Mozambique: an open label non-randomized interventional trial |
| Q95839917 | Genetic association of co-trimoxazole-induced severe cutaneous adverse reactions is phenotype-specific: HLA class I genotypes and haplotypes |
| Q35975609 | Impact of daily cotrimoxazole on clinical malaria and asymptomatic parasitemias in HIV-exposed, uninfected infants |
| Q37350165 | Malaria burden in a birth cohort of HIV-exposed uninfected Ugandan infants living in a high malaria transmission setting |
| Q55546839 | Morbidity and mortality in HIV-exposed uninfected children |
| Q91619640 | Peripheral blood mononuclear cell transcriptomes reveal an over-representation of down-regulated genes associated with immunity in HIV-exposed uninfected infants |
| Q37538729 | Plasmodium falciparum Genetic Diversity in Continental Equatorial Guinea before and after Introduction of Artemisinin-Based Combination Therapy |
| Q92120333 | Surgical versus nonsurgical treatment of primary acute patellar dislocation: A systematic review and meta-analysis |
| Q35217416 | The effect of daily co-trimoxazole prophylaxis on natural development of antibody-mediated immunity against P. falciparum malaria infection in HIV-exposed uninfected Malawian children |
| Q53644346 | What is the best therapy for Whipple's disease? Our point of view. |
Search more.